Home

Élucidation Ombre Remise à neuf mannkind inhaled insulin Grincer Cilia Gémissements

Is Inhaled Insulin Safe During the COVID-19 Outbreak?
Is Inhaled Insulin Safe During the COVID-19 Outbreak?

Inhaled insulin: Sanofi alone as Big Pharma declines to revisit past
Inhaled insulin: Sanofi alone as Big Pharma declines to revisit past

Future of Afrezza Inhaled Insulin: Interview with Michael Castagna, CCO of  MannKind Corp. | Medgadget
Future of Afrezza Inhaled Insulin: Interview with Michael Castagna, CCO of MannKind Corp. | Medgadget

What? MannKind posts best-ever quarter of inhaled-insulin sales - STAT
What? MannKind posts best-ever quarter of inhaled-insulin sales - STAT

MannKind is Fixing Foundations to Build a Big Future | Insulin Nation
MannKind is Fixing Foundations to Build a Big Future | Insulin Nation

MannKind's (MNKD) Afrezza Lags Behind Biggest Failure in Inhaled Insulin -  TheStreet
MannKind's (MNKD) Afrezza Lags Behind Biggest Failure in Inhaled Insulin - TheStreet

MannKind celebrates as inhaled insulin clears pivotal trials - PMLiVE
MannKind celebrates as inhaled insulin clears pivotal trials - PMLiVE

NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™  (aviptadil) Inhaler for Respiratory Conditions
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions

Harro Höfliger ‐ Administration of insulin using DPI inhalers
Harro Höfliger ‐ Administration of insulin using DPI inhalers

Sanofi Terminates Partnership for MannKind's Inhaled Insulin, Afrezza
Sanofi Terminates Partnership for MannKind's Inhaled Insulin, Afrezza

Afrezza (recombinant human insulin inhalation) / MannKind
Afrezza (recombinant human insulin inhalation) / MannKind

MannKind Corporation Announces FDA Approval of Novel, Rapid-Acting Inhaled  Insulin for the Treatment of Diabetes
MannKind Corporation Announces FDA Approval of Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

MannKind Corp.: Bullish On High-Growth Inhaled Insulin Opportunity (NASDAQ: MNKD) | Seeking Alpha
MannKind Corp.: Bullish On High-Growth Inhaled Insulin Opportunity (NASDAQ: MNKD) | Seeking Alpha

Afrezza Inhaled Insulin: What You Should Know
Afrezza Inhaled Insulin: What You Should Know

Sanofi cuts $925m deal for MannKind's inhaled insulin - PMLiVE
Sanofi cuts $925m deal for MannKind's inhaled insulin - PMLiVE

MannKind Corp.: Bullish On High-Growth Inhaled Insulin Opportunity (NASDAQ: MNKD) | Seeking Alpha
MannKind Corp.: Bullish On High-Growth Inhaled Insulin Opportunity (NASDAQ: MNKD) | Seeking Alpha

Sanofi and MannKind announce global licensing agreement for Afrezza® ( insulin human) rapid-acting inhaled insulin - Drug Target Review
Sanofi and MannKind announce global licensing agreement for Afrezza® ( insulin human) rapid-acting inhaled insulin - Drug Target Review

Sales of MannKind's inhaled insulin continue slow start - Los Angeles Times
Sales of MannKind's inhaled insulin continue slow start - Los Angeles Times

Talking to Your Doctor About Inhaled Insulin
Talking to Your Doctor About Inhaled Insulin

Inhaled insulin stymied by drive for value - MM+M - Medical Marketing and  Media
Inhaled insulin stymied by drive for value - MM+M - Medical Marketing and Media

Firms Target Insulin Market
Firms Target Insulin Market

Sanofi in $150m deal to commercialise Mannkind's inhaled insulin
Sanofi in $150m deal to commercialise Mannkind's inhaled insulin

MannKind plans to seek new marketing partner for insulin drug - Los Angeles  Times
MannKind plans to seek new marketing partner for insulin drug - Los Angeles Times

New form of insulin can be inhaled rather tha | EurekAlert!
New form of insulin can be inhaled rather tha | EurekAlert!

MannKind's inhaled insulin drug proves hard for diabetics to get - Los  Angeles Times
MannKind's inhaled insulin drug proves hard for diabetics to get - Los Angeles Times

Cipla partners with MannKind for Afrezza - inhaled insulin - Express Pharma
Cipla partners with MannKind for Afrezza - inhaled insulin - Express Pharma

Switching to Afrezza Inhaled Insulin: Tips from a Diabetes Educator
Switching to Afrezza Inhaled Insulin: Tips from a Diabetes Educator